References
- Kumanan T, Sujanitha V, Sreeharan N. Amoebic liver abscess: a neglected tropical disease. Lancet Infect Dis. 2020;20(2):160–162. doi: 10.1016/S1473-3099(19)30696-6.
- Ghelfenstein-Ferreira T, Gits-Muselli M, Dellière S, et al. Entamoeba histolytica DNA detection in serum from patients with suspected amoebic liver abscess. J Clin Microbiol. 2020;58(10):10–128. doi: 10.1128/JCM.01153-20.
- Hooshyar H, Rostamkhani P. Accurate laboratory diagnosis of human intestinal and extra-intestinal amoebiasis. Gastroenterol Hepatol Bed Bench. 2022;15(4):343–359. doi: 10.22037/ghfbb.v15i4.2496.
- Agrawal S, Verma N, Perumalla S, et al. Decreasing trend of seroprevalence of hepatic amoebiasis in tertiary care hospital of North India: 2010 –2015. J Lab Physicians. 2018;10(1):31–33. doi: 10.4103/JLP.JLP_91_17.
- Tharmaratnam T, Kumanan T, Iskandar MA, et al. Entamoeba histolytica and amoebic liver abscess in Northern Sri Lanka: a public health problem. Trop Med Health. 2020;48(1):2. doi: 10.1186/s41182-020-0193-2.
- Neill L, Edwards F, Collin SM, et al. Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess. BMC Infect Dis. 2019;19(1):490. doi: 10.1186/s12879-019-4127-8.
- Lal SB, Venkatesh V, Kumar A, et al. Liver abscess in children-experience from a single tertiary care center of North India: etiology, clinical profile and predictors of complications. Pediatr Infect Dis J. 2021;40(5):e179-84–e184. doi: 10.1097/INF.0000000000003053.
- Khim G, Em S, Mo S, et al. Liver abscess: diagnostic and management issues found in the low resource setting. Br Med Bull. 2019;132(1):45–52. doi: 10.1093/bmb/ldz032.
- Weerakoon KG, McManus DP. Cell-free DNA as a diagnostic tool for human parasitic infections. Trends Parasitol. 2016;32(5):378–391. doi: 10.1016/j.pt.2016.01.006.
- Toribio L, Santivanez S, Scott AL, et al. Diagnostic urinary cfDNA detected in human cystic echinococcosis. Mol Biochem Parasitol. 2020; 239:111314. doi: 10.1016/j.molbiopara.2020.111314.
- Archer J, LaCourse JE, Webster BL, et al. An update on non-invasive urine diagnostics for human-infecting parasitic helminths: what more could be done and how? Parasitology 2020;147(8):873–888. doi: 10.1017/S0031182019001732.
- Tuck MK, Chan DW, Chia D, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res. 2009;8(1):113–117. doi: 10.1021/pr800545q.
- Khairnar K, Parija SC, Palaniappan R. Diagnosis of intestinal amoebiasis by using nested polymerase chain reaction-restriction fragment length polymorphism assay. J Gastroenterol. 2007;42(8):631–640. doi: 10.1007/s00535-007-2080-6.
- Polatoglou E, Mayer Z, Ungerer V, et al. Isolation and quantification of plasma cell-free DNA using different manual and automated methods. Diagnostics. 2022;12(10):2550. doi: 10.3390/diagnostics12102550.
- Diefenbach RJ, Lee JH, Kefford RF, et al. Evaluation of commercial kits for purification of circulating free DNA. Cancer Genet. 2018;228-229:21–27. doi: 10.1016/j.cancergen.2018.08.005.
- Hailu T, Amor A, Nibret E, et al. Evaluation of five diagnostic methods for Strongyloides stercoralis infection in Amhara national regional state, northwest Ethiopia. BMC Infect Dis. 2022;22(1):297. doi: 10.1186/s12879-022-07299-1.
- Zeleke AJ, Addisu A, Derso A, et al. Evaluation of hookworm diagnosis techniques from patients in Debre Elias and Sanja districts of the Amhara region, Ethiopia. J Parasitol Res. 2021;2021:6682330–6682337. doi: 10.1155/2021/6682330.
- Bansal Y, Maurya V, Bohra GP, et al. Clinical and laboratory profile of patients with amoebic liver abscess. Trop Parasitol. 2022;12(2):113–118. doi: 10.4103/tp.TP_38_20.
- de Miranda FS, Barauna VG, Dos Santos L, et al. Properties and application of cell-free DNA as a clinical biomarker. Int J Mol Sci. 2021;22(17):9110. doi: 10.3390/ijms22179110.
- Hu Z, Chen H, Long Y, et al. The main sources of circulating cell-free DNA: apoptosis, necrosis and active secretion. Crit Rev Oncol Hematol. 2021;157:103166. doi: 10.1016/j.critrevonc.2020.103166.
- Postel M, Roosen A, Laurent-Puig P, et al. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumour DNA: a cancer diagnostic perspective. Expert Rev Mol Diagn. 2018;18(1):7–17. doi: 10.1080/14737159.2018.1400384.
- Rigothier MC, Khun H, Tavares P, et al. Fate of Entamoeba histolytica during establishment of amoebic liver abscess analyzed by quantitative radioimaging and histology. Infect Immun. 2002;70(6):3208–3215. doi: 10.1128/IAI.70.6.3208-3215.2002.
- Ozturk EA, Caner A. Liquid biopsy for promising non-invasive diagnostic biomarkers in parasitic infections. Acta Parasitol. 2022;67(1):1–17. doi: 10.1007/s11686-021-00444-x.
- Rajar P, Åsegg-Atneosen M, Saugstad OD, et al. Quantification of circulating cell-free DNA (cfDNA) in urine using a newborn piglet model of asphyxia. PLoS One. 2019; 14(12):e0227066. doi: 10.1371/journal.pone.0227066.
- Lu T, Li J. Clinical applications of urinary cell-free DNA in cancer: current insights and promising future. Am J Cancer Res. 2017;7(11):2318–2332.
- Wang XS, Zhao MQ, Zhang L, et al. Cell-free DNA in serum and urine as a diagnostic tool for bladder cancer: a meta-analysis. Am J Transl Res. 2018;10(7):1935.